비교리스트

 카트 문의
시장보고서
상품코드
1544120

세계의 경카테터 대동맥판 치환술 시장

Transcatheter Aortic Valve Replacement Procedures
발행일: | 리서치사: Global Industry Analysts, Inc. | 페이지 정보: 영문 197 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 경카테터 대동맥판 치환술 시장은 2030년까지 183억 달러에 달할 전망

2023년에 73억 달러로 추정되는 세계의 경카테터 대동맥판 치환술 시장은 분석 기간인 2023-2030년에 CAGR 14.0%로 성장하며, 2030년에는 183억 달러에 달할 것으로 예측됩니다. 본 리포트에서 분석한 부문의 하나인 경대퇴 시술은 CAGR 14.8%를 기록하며, 분석 기간 종료까지 170억 달러에 달할 것으로 예측됩니다. 쇄골하 시술 부문의 성장률은 분석 기간 중 CAGR 7.4%로 추정됩니다.

미국 시장은 20억 달러로 추정, 중국은 CAGR 13.0%로 성장 예측

미국의 경카테터 대동맥판 치환술 시장은 2023년에 20억 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 27억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2023-2030년 CAGR은 13.0%입니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 12.9%와 11.8%로 예측됩니다. 유럽에서는 독일이 CAGR 약 9.9%로 성장할 것으로 예측됩니다.

세계의 경카테터 대동맥판 치환술 시장 - 주요 동향과 촉진요인 정리

경카테터 대동맥판 치환술이란 무엇이며, 왜 중요한가?

경카테터 대동맥판 치환술(TAVR)은 중증의 대동맥판 협착증(대동맥판이 좁아져 심장으로부터 혈류가 제한되는 상태) 치료에 이용되는 저침습수술입니다. TAVR 수술에서는 일반적으로 대퇴동맥을 통해 카테터를 삽입하여 판막을 교체하므로 개심술이 필요하지 않습니다. TAVR은 고령이나 동반 질환으로 인해 기존 수술적 대동맥판막 치환술(SAVR)의 위험이 높은 환자들에게 매우 중요한 수술로, 회복 시간이 짧고 합병증 위험이 낮은 최소 침습적 대안을 제공하여 대동맥판막 협착증 치료의 환자 예후를 개선하는 데 중요한 대안이 되고 있습니다. 중요한 대안이 되고 있습니다.

TAVR 시술은 어떻게 환자 결과를 개선할 수 있는가?

TAVR 치료는 중증 대동맥판막 협착증에 대해 보다 안전하고 덜 침습적인 치료법을 제공함으로써 환자의 예후를 개선할 수 있으며, TAVR은 최소 침습적이기 때문에 기존 개심술에 비해 입원 기간이 짧고 회복이 빠르며 통증이 적습니다. 이 접근법은 또한 감염 및 출혈과 같은 개심술에서 더 흔한 합병증의 위험을 최소화하며, TAVR은 호흡 곤란, 피로 및 흉통과 같은 대동맥판막 협착증의 증상을 완화하여 환자의 삶의 질을 크게 향상시키는 것으로 나타났습니다. 또한 TAVR은 특히 SAVR에 적합하지 않은 고위험군 환자에서 사망률 감소 및 장기 생존율 향상과 관련이 있습니다.

TAVR 시술의 채택이 증가하는 이유는 무엇인가?

TAVR 시술의 채택은 몇 가지 중요한 요인으로 인해 증가하고 있습니다. 전 세계 인구의 고령화와 대동맥판막 협착증의 유병률 증가, 특히 노년층의 대동맥판막 협착증에 대한 효과적인 치료 옵션에 대한 수요가 증가하고 있습니다. 의료기술과 영상진단 기술의 발전으로 TAVR 시술의 안전성과 유효성이 향상되어 더 많은 환자들이 이용할 수 있게 되었습니다. 기존 수술적 접근법 대비 TAVR의 장점을 입증하는 임상시험과 연구도 의료진 사이에서 TAVR의 수용성을 높이는 데 일조하고 있습니다. 또한 차세대 TAVR 기기의 개발과 중등도 및 저위험 환자를 포함한 적응증 확대도 TAVR 시술의 채택을 촉진하고 있습니다. 환자의 예후와 삶의 질 향상에 중점을 두면서 대동맥판막협착증에 대한 선호도가 높아지면서 TAVR에 대한 수요가 더욱 증가하고 있습니다.

TAVR 시술 시장의 성장을 가속하는 요인은?

경피적 대동맥판막 치환술 시장의 성장은 몇 가지 요인에 의해 주도되고 있습니다. 특히 고령화 사회에서 대동맥판막 협착증의 유병률 증가는 효과적인 치료 옵션에 대한 큰 수요를 창출하고 있으며, TAVR 장비 및 시술의 기술적 발전은 이러한 시술의 안전성과 효능을 향상시켜 채택을 촉진하고 있습니다. 기존 수술적 접근법 대비 TAVR의 장점을 지원하는 임상적 증거는 의료진과 환자들 사이에서 TAVR이 점점 더 많이 받아들여지고 있는 데 일조하고 있습니다. TAVR의 적응증 확대는 중등도 및 저위험군 환자들에 대한 TAVR의 적응증 확대로 시장 성장을 더욱 촉진하고 있습니다. 회복 시간을 단축하고 환자의 예후를 개선하는 최소침습적 시술에 대한 관심도 TAVR에 대한 수요를 촉진하고 있습니다. 또한 TAVR의 기술 및 치료 결과를 개선하기 위한 지속적인 연구개발 노력과 유리한 상환 정책도 시장 확대에 큰 기여를 하고 있습니다.

조사 대상 기업의 예(주목 47사)

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Bracco SpA
  • Edwards Lifesciences Corporation
  • Jenavalve Technology, Inc.
  • Medtronic PLC
  • Meril Life Sciences Pvt., Ltd.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장의 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

KSA 24.09.04

Global Transcatheter Aortic Valve Replacement Procedures Market to Reach US$18.3 Billion by 2030

The global market for Transcatheter Aortic Valve Replacement Procedures estimated at US$7.3 Billion in the year 2023, is expected to reach US$18.3 Billion by 2030, growing at a CAGR of 14.0% over the analysis period 2023-2030. Transfemoral Procedure, one of the segments analyzed in the report, is expected to record a 14.8% CAGR and reach US$17.0 Billion by the end of the analysis period. Growth in the Subclavian Procedure segment is estimated at 7.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.0 Billion While China is Forecast to Grow at 13.0% CAGR

The Transcatheter Aortic Valve Replacement Procedures market in the U.S. is estimated at US$2.0 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.7 Billion by the year 2030 trailing a CAGR of 13.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.9% and 11.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.9% CAGR.

Global Transcatheter Aortic Valve Replacement Procedures Market - Key Trends & Drivers Summarized

What are Transcatheter Aortic Valve Replacement Procedures and Why are They Critical?

Transcatheter Aortic Valve Replacement (TAVR) Procedures are minimally invasive surgeries used to treat severe aortic stenosis, a condition where the aortic valve becomes narrowed, restricting blood flow from the heart. TAVR procedures involve the insertion of a replacement valve via a catheter, usually through the femoral artery, eliminating the need for open-heart surgery. These procedures are critical for patients who are at high risk for conventional surgical aortic valve replacement (SAVR) due to age or comorbid conditions. TAVR offers a less invasive alternative with shorter recovery times and reduced risk of complications, making it a vital option for improving patient outcomes in aortic stenosis treatment.

How Do TAVR Procedures Enhance Patient Outcomes?

TAVR Procedures enhance patient outcomes by providing a safer and less invasive treatment option for severe aortic stenosis. The minimally invasive nature of TAVR results in shorter hospital stays, faster recovery times, and reduced pain compared to traditional open-heart surgery. This approach also minimizes the risk of complications, such as infections and bleeding, which are more common in open-heart procedures. TAVR has shown to significantly improve the quality of life for patients by alleviating symptoms of aortic stenosis, such as shortness of breath, fatigue, and chest pain. Additionally, TAVR is associated with lower mortality rates and better long-term survival, particularly in high-risk patients who are not suitable candidates for SAVR.

Why is the Adoption of TAVR Procedures Increasing?

The adoption of TAVR Procedures is increasing due to several critical factors. The aging global population and the rising prevalence of aortic stenosis, particularly among the elderly, create a growing demand for effective treatment options. Advances in medical technology and imaging techniques have improved the safety and efficacy of TAVR procedures, making them more accessible to a broader patient population. Clinical trials and studies demonstrating the benefits of TAVR over traditional surgical approaches have also contributed to its growing acceptance among healthcare providers. Additionally, the development of next-generation TAVR devices and expanding indications for their use, including intermediate-risk and low-risk patients, are driving the adoption of these procedures. The focus on improving patient outcomes and quality of life further propels the demand for TAVR as a preferred treatment option for aortic stenosis.

What Factors are Driving the Growth of the TAVR Procedures Market?

The growth in the Transcatheter Aortic Valve Replacement Procedures market is driven by several factors. The increasing prevalence of aortic stenosis, particularly among the aging population, creates a significant demand for effective treatment options. Technological advancements in TAVR devices and procedural techniques enhance the safety and efficacy of these procedures, driving their adoption. Clinical evidence supporting the benefits of TAVR over traditional surgical approaches contributes to its growing acceptance among healthcare providers and patients. Expanding indications for TAVR, including its use in intermediate-risk and low-risk patients, further fuel market growth. The emphasis on minimally invasive procedures that offer faster recovery times and improved patient outcomes also drives the demand for TAVR. Additionally, ongoing research and development efforts to improve TAVR technology and outcomes, along with favorable reimbursement policies, significantly contribute to market expansion.

Select Competitors (Total 47 Featured) -

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Bracco SpA
  • Edwards Lifesciences Corporation
  • Jenavalve Technology, Inc.
  • Medtronic PLC
  • Meril Life Sciences Pvt., Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Transcatheter Aortic Valve Replacement Procedures - Global Key Competitors Percentage Market Share in 2024 (E)
    • Global Economic Update
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Cardiovascular Diseases
    • Growing Aging Population and Associated Heart Conditions
    • Advancements in TAVR Device Technology
    • Rising Adoption of Minimally Invasive Procedures
    • Expansion of Indications for TAVR Procedures
    • Integration of Imaging and Navigation Technologies
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Transcatheter Aortic Valve Replacement Procedures by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Other Procedures by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Other Procedures by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Other Procedures by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Transcatheter Aortic Valve Replacement Procedures Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Transfemoral Procedure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Transfemoral Procedure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Transfemoral Procedure by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Subclavian Procedure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Subclavian Procedure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Subclavian Procedure by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Transcatheter Aortic Valve Replacement Procedures Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: USA 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Procedure - Percentage Breakdown of Value Sales for Transfemoral Procedure, Subclavian Procedure and Other Procedures for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: Canada 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Procedure - Percentage Breakdown of Value Sales for Transfemoral Procedure, Subclavian Procedure and Other Procedures for the Years 2014, 2024 & 2030
  • JAPAN
    • Transcatheter Aortic Valve Replacement Procedures Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: Japan 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Procedure - Percentage Breakdown of Value Sales for Transfemoral Procedure, Subclavian Procedure and Other Procedures for the Years 2014, 2024 & 2030
  • CHINA
    • Transcatheter Aortic Valve Replacement Procedures Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: China 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Procedure - Percentage Breakdown of Value Sales for Transfemoral Procedure, Subclavian Procedure and Other Procedures for the Years 2014, 2024 & 2030
  • EUROPE
    • Transcatheter Aortic Valve Replacement Procedures Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Transcatheter Aortic Valve Replacement Procedures by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Procedure - Percentage Breakdown of Value Sales for Transfemoral Procedure, Subclavian Procedure and Other Procedures for the Years 2014, 2024 & 2030
  • FRANCE
    • Transcatheter Aortic Valve Replacement Procedures Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: France 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Procedure - Percentage Breakdown of Value Sales for Transfemoral Procedure, Subclavian Procedure and Other Procedures for the Years 2014, 2024 & 2030
  • GERMANY
    • Transcatheter Aortic Valve Replacement Procedures Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Germany 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Procedure - Percentage Breakdown of Value Sales for Transfemoral Procedure, Subclavian Procedure and Other Procedures for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Italy 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Procedure - Percentage Breakdown of Value Sales for Transfemoral Procedure, Subclavian Procedure and Other Procedures for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Transcatheter Aortic Valve Replacement Procedures Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: UK 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Procedure - Percentage Breakdown of Value Sales for Transfemoral Procedure, Subclavian Procedure and Other Procedures for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 44: Rest of Europe Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Rest of Europe Historic Review for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Rest of Europe 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Procedure - Percentage Breakdown of Value Sales for Transfemoral Procedure, Subclavian Procedure and Other Procedures for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Transcatheter Aortic Valve Replacement Procedures Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 47: Asia-Pacific Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Asia-Pacific Historic Review for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Asia-Pacific 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Procedure - Percentage Breakdown of Value Sales for Transfemoral Procedure, Subclavian Procedure and Other Procedures for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 50: Rest of World Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of World Historic Review for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Rest of World 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Procedure - Percentage Breakdown of Value Sales for Transfemoral Procedure, Subclavian Procedure and Other Procedures for the Years 2014, 2024 & 2030

IV. COMPETITION

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제